Drugmakers Lose Bid to Block California Price Transparency Law
SACRAMENTO, Calif. (CN) — The pharmaceutical industry’s effort to block California’s requirement that drug companies publicly notify and explain major price increases has stalled, with a federal judge ruling the landmark transparency law does not violate the First Amendment. Siding with the state, U.S. District Judge Morrison England Jr. squashed an industry group’s arguments that the 2017 bill infringes drugmakers’ free speech and regulates interstate commerce. Noting the Pharmaceutical Research and Manufacturers of America (PhRMA) willingly bypassed discovery and pushed for summar...
Source: courthousenews.com